Revenue · 2011–2025

Biogen revenue

$9.9B+2.2% · FY2025

Biogen (BIIB) reported $9.9B in revenue for fiscal 2025, +2.2% year on year.

$5.0B2011$5.5B2012$6.9B2013$9.7B2014$10.8B2015$11.4B2016$12.3B2017$13.5B2018$14.4B2019$13.4B2020$11.0B2021$10.2B2022$9.8B2023$9.7B2024$9.9B2025
Biogen — Revenue, 2011–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$9.9B+2.2%Open →
FY20242024-12-31$9.7B−1.6%Open →
FY20232023-12-31$9.8B−3.3%Open →
FY20222022-12-31$10.2B−7.4%Open →
FY20212021-12-31$11.0B−18.3%Open →
FY20202020-12-31$13.4B−6.5%Open →
FY20192019-12-31$14.4B+6.9%Open →
FY20182018-12-31$13.5B+9.6%Open →
FY20172017-12-31$12.3B+7.2%Open →
FY20162016-12-31$11.4B+6.4%Open →
FY20152015-12-31$10.8B+10.9%Open →
FY20142014-12-31$9.7B+40.0%Open →
FY20132013-12-31$6.9B+25.7%Open →
FY20122012-12-31$5.5B+9.3%Open →
FY20112011-12-31$5.0B—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +4.9%

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Biogen revenue |url=https://companiesranked.com/en/company/biogen/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Biogen revenue. CompaniesRanked. https://companiesranked.com/en/company/biogen/revenue

BibTeX

@misc{companiesranked-en-company-biogen-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Biogen revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/biogen/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0000875045-26-000013 · February 6, 2026

{{cite web |title=Biogen revenue — 10-K (0000875045-26-000013) |url=https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-06}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Biogen overview